Clinical Trial Update: Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Painful Diabetic Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of eslicarbazepine acetate for painful diabetic neuropathy; results have been posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Neuropathy

Drugs mentioned

• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Painful Diabetic Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2013-05-22